Literature DB >> 4216341

Rubella precipitin response in natural infection and in vaccination.

N R Paul, A J Rhodes, J B Campbell, N A Labzoffsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4216341     DOI: 10.1007/bf01242877

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  8 in total

1.  SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES.

Authors:  M STOKER; I MACPHERSON
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

Review 2.  Laboratory diagnosis of rubella virus infections.

Authors:  S Iwakata; A H Rhodes; N A Labzoffsky
Journal:  Can Med Assoc J       Date:  1973-04-07       Impact factor: 8.262

3.  [Immunization against rubella. Study of serum antibiotics after immunoglobulin injection].

Authors:  Y Aurousseau; J Maurin; Y Darbois
Journal:  Nouv Presse Med       Date:  1973-07-14

4.  Precipitinogens of rubella virus-infected cells.

Authors:  G L Le Bouvier
Journal:  Proc Soc Exp Biol Med       Date:  1969-01

5.  Precipitin responses to rubella vaccine RA 27-3.

Authors:  G L Le Bouvier; S A Plotkin
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

6.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

7.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

8.  The significance of specific IgM antibody in the diagnosis of rubella employing the immunofluorescence technique.

Authors:  S Iwakata; A J Rhodes; N A Labzoffsky
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

  8 in total
  3 in total

1.  Demonstration by immunoelectro-osmophoresis of precipitating antibodies to a purified rubella virus antigen.

Authors:  P C Grauballe; B F Vestergaard; A Hornsleth; J Leerhoy; T Johnsson
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Antibody responses in patients with rubella infection determined by passive hemagglutination, hemagglutination inhibition, complement fixation, and solid-phase radioimmunoassay tests.

Authors:  O H Meurman
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

3.  Rubella in Orkney: seroepidemiology and vaccination.

Authors:  M A Moffat; S N Heywood; E Laughton; J J Gould; D S Freestone
Journal:  J Hyg (Lond)       Date:  1977-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.